Skip to main content

Table 2 Univariate and multivariate Cox regression analyses for development of interstitial lung disease during the 9-year follow-up period

From: Risk factors for interstitial lung disease: a 9-year Nationwide population-based study

Risk factor

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

Men (reference: women)

1.9 (1.7–2.1)

< 0.001

1.9 (1.7–2.1)

< 0.001

Age group (years) (reference: 40–49)

 50–59

1.9 (1.7–2.2)

< 0.001

1.9 (1.7–2.2)

< 0.001

 60–69

4.3 (3.8–4.9)

< 0.001

4.1 (3.6–4.7)

< 0.001

  ≥70

7.1 (6.2–8.2)

< 0.001

6.9 (5.9–8.0)

< 0.001

Diabetes (reference: no)

1.6 (1.5–1.8)

< 0.001

1.1 (0.9–1.2)

0.06

COPD (reference: no)

3.7 (3.2–4.2)

< 0.001

1.8 (1.6–2.1)

< 0.001

GERD (reference: no)

1.3 (1.1–1.5)

< 0.001

1.0 (0.9–1.3)

0.31

History of herpes (reference: no)

0.97 (0.7–1.2)

0.85

0.9 (0.7–1.2)

0.92

History of tuberculosis (reference: no)

3.0 (2.4–3.7)

< 0.001

1.5 (1.1–1.9)

0.003

History of pneumonia (reference: no)

2.2 (1.8–2.7)

< 0.001

1.6 (1.3–2.0)

< 0.001

Hepatitis C (reference: no)

2.1 (1.4–3.0)

< 0.001

1.6 (1.1–2.3)

0.01

Hepatitis B (reference: no)

1.0 (0.8–1.3)

0.84

0.8 (0.7–1.1)

0.39

Smoker (reference: never smoker)

1.4 (1.3–1.6)

< 0.001

1.2 (1.1–1.4)

< 0.001

Household income, % (reference: 81–100)

 41–80

0.8 (0.8–0.9)

0.04

0.9 (0.8–1.0)

0.35

 11–40

1.0 (0.9–1.1)

0.85

0.9 (0.8–1.1)

0.87

 0–10

1.1 (0.8–1.6)

0.39

1.1 (0.7–1.5)

0.59

  1. HR hazard ratio, CI confidence interval, COPD chronic obstructive pulmonary disease, GERD gastroesophageal reflux disorder